GSTM1 Antibodies

Santa Cruz Biotechnology provides a broad selection of GSTM1 monoclonal antibodies for research applications. GSTM1 monoclonal antibodies are compatible with western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GSTM1, or Glutathione S-Transferase Mu 1, plays a crucial role in the detoxification of harmful compounds and the metabolism of drugs. It is involved in the conjugation of glutathione to various substrates, facilitating their excretion and reducing cellular damage from oxidative stress. The expression levels of GSTM1 can significantly impact individual susceptibility to certain diseases, making it an important target for research in pharmacogenomics and cancer studies. GSTM1 monoclonal antibodies enable researchers to investigate cellular detoxification mechanisms and their relationship to disease progression. Understanding GSTM1's role in drug metabolism can lead to improved therapeutic strategies and personalized medicine approaches. GSTM1 research using Santa Cruz Biotechnology monoclonal antibodies continues to advance our understanding of cellular defense mechanisms and drug responses.